HomeTagsMedicine

Medicine - Page 15

Stories from Medicine come first, newest first, then stories from connected topics (AI Science & Health, Healthcare, Hub: Tech for Good, healthcare AI, Biotech, drug discovery), each labelled with where it comes from. This view is not indexed by search engines.

Latest

Oracle and AstraZeneca to Explore AI for Finding Clinical-Trial Patients

Oracle and AstraZeneca signed a non-binding agreement to explore AI and real-world data to find clinical-trial patients sooner. No terms or dates given.

Lilly Taps Metis TechBio’s AI to Steer Medicines to Target Tissues

Metis TechBio will use AI to design tissue-targeted drug carriers for Eli Lilly. Upfront cash is low double-digit millions; milestones run up to $1.1bn.

Scripps Research Gets Over 14 Million GPU Hours From Huang Foundation

Scripps Research gets more than 14 million GPU hours from the Huang Foundation via CoreWeave/NVIDIA. In-kind; no dollar value.

Johns Hopkins-Led Team Wins Up to $52.1m to Model Protein Misfolding

Johns Hopkins leads an ARPA-H award of up to $52.1m over four years for an open protein-misfolding AI model, starting with Parkinson’s and Ewing sarcoma.

Google Research Runs AI Agents on Wet-Lab Robots in Closed Loops

Google Research: VERID digital twin on PyLabRobot, closed-loop aptamers, nanomolar FAP binders. Authors’ self-published results, not peer-reviewed.

China Proposes Adding 40 AI, Biomedicine and Solar Technologies to Its Export-Control Catalogue

China's commerce and science ministries propose adding 40 AI, biomedicine and solar technologies to the export-control catalogue, with registration now.

OpenAI Introduces the Rosalind Academic Plan for US University Labs

OpenAI’s Rosalind Academic Plan offers eligible US university labs up to 30 free seats for 12 months; GPT-Rosalind needs trusted-access approval.

Google DeepMind Shows Its Antigravity Agent Finding a New Antimicrobial Peptide Candidate, Which Still Needs Lab Testing

Google DeepMind says its Antigravity agent helped find a new antimicrobial peptide candidate. It is a computational lead now in lab testing.

Sanofi Options First Development Candidate From Its Recursion AI Collaboration

Sanofi has optioned a potential first-in-class oral immunology candidate from Recursion, triggering a $10m milestone. Phase 1 is planned for 2027.

insitro and AstraZeneca Sign AI Collaboration to Hunt Drugs for MASH and Cardiomyopathies

insitro gets $40m upfront and is eligible for up to about $1.46bn in potential milestones in an AstraZeneca AI deal for MASH and heart disease.

Latest on TSN

Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.